Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis

Background: Specific isoniazid (INH) resistance conferring mutations have been shown to impact the likelihood of tuberculosis (TB) transmission. However, their role in the clinical presentation and outcomes of TB has not been evaluated. Methods: We include